Inventor · disambiguated record
Wouter Korver
Also filed as: KORVER WOUTER
22 granted patents·12 pending applications·180 citations·filing 2005–2024
95Inventor score
Files withTAKEDA PHARMACEUTICALS CO9ABO ARIE4ALLAKOS INC3ARCA BIOPHARMA INC3TEVA PHARMACEUTICALS AUSTRALIA PTY LTD3
Top patents by PatentIndex Score
34 records- 0198US8362211B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2011·Granted Jan 29, 2013·71 cites·12 claims
- 0297US11414496B2Anti-CD38 binding domainsMILLENNIUM PHARM INC·Filed 2020·Granted Aug 16, 2022·4 cites·21 claims
- 0395US9676869B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 13, 2017·12 cites·20 claims
- 0494US10494444B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 3, 2019·8 cites·10 claims
- 0594US10336833B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jul 2, 2019·9 cites·30 claims
- 0693US2025171561A1Anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0792US8926969B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Jan 6, 2015·14 cites·17 claims
- 0892US8536310B2Antibodies to CLL-1ABO ARIE·Filed 2008·Granted Sep 17, 2013·22 cites·10 claims
- 0990US9790285B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 17, 2017·7 cites·24 claims
- 1090US9102744B2Conjugated anti-CD38 antibodiesELIAS KATHLEEN ANN·Filed 2011·Granted Aug 11, 2015·13 cites·17 claims
- 1187US9611322B2Fusions of antibodies to CD38 and attenuated interferon alphaTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2014·Granted Apr 4, 2017·6 cites·18 claims
- 1286US7847067B2Antibodies to NTB-AARCA BIOPHARMA INC·Filed 2007·Granted Dec 7, 2010·5 cites·16 claims
- 1385US12209138B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jan 28, 2025·0 cites·17 claims
- 1483US10981986B2Fusions of antibodies to CD38 and attenuated interferon alphaTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2017·Granted Apr 20, 2021·2 cites·21 claims
- 1583US7625549B2Determining the risk of human anti-human antibodies in transgenic miceAMGEN FREMONT INC·Filed 2005·Granted Dec 1, 2009·3 cites·24 claims
- 1680US8193320B2Antibodies to NTB-AABO ARIE·Filed 2010·Granted Jun 5, 2012·1 cites·17 claims
- 1778US11434304B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 6, 2022·0 cites·28 claims
- 1876US12312411B2Anti-CD38 binding domainsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted May 27, 2025·0 cites·20 claims
- 1976US11773162B2Anti-Siglec-7 antibodies for the treatment of cancerALLAKOS INC·Filed 2017·Granted Oct 3, 2023·2 cites·14 claims
- 2072US2020031951A1Conjugated anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 2166US8198508B2Reducing the risk of human anti-human antibodies through V gene manipulationKELLERMANN SIRID-AIMEE·Filed 2009·Granted Jun 12, 2012·1 cites·15 claims
- 2263US8993726B2Antibodies to NTB-AABO ARIE·Filed 2012·Granted Mar 31, 2015·0 cites·12 claims
- 2362US2013344514A1Reducing the risk of human anti-human antibodies through v gene manipulationAMGEN FREMONT INC·Filed 2013·Application pending·0 cites
- 2462US2017334989A1Antibodies to ntb-aARCA BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 2561US2024084005A1Anti-siglec-6 antibodies and methods of use thereofALLAKOS INC·Filed 2023·Application pending·0 cites
- 2660US2025042996A1Antibodies to anti-siglec-9 and multispecific antibodies targeting siglec-7 and siglec-9BEBBINGTON CHRISTOPHER·Filed 2022·Application pending·0 cites
- 2759US8597615B2Methods of monitoring a human anti-human antibody response and inhibitors thereofKELLERMANN SIRID-AIMEE·Filed 2012·Granted Dec 3, 2013·0 cites·25 claims
- 2859US2015376273A1Antibodies to ntb-aARCA BIOPHARMA INC·Filed 2015·Application pending·0 cites
- 2954US2016367695A1Polypeptide constructs and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2016·Application pending·0 cites
- 3050US2010291108A1Antibodies to irem-1ABO ARIE·Filed 2008·Application pending·0 cites
- 3149US11912766B2Anti-Siglec-7 antibodies having reduced effector functionALLAKOS INC·Filed 2019·Granted Feb 27, 2024·0 cites·11 claims
- 3249US2017299590A1Methods and compositions for systemic lupus erythematosusNODALITY INC·Filed 2017·Application pending·0 cites
- 3345US2016245794A1Methods and compositions for systemic lupus erythematosusNODALITY INC·Filed 2015·Application pending·0 cites
- 3439US2005260679A1Reducing the risk of human anti-human antibodies through V gene manipulationKELLERMAN SIRID-AIMEE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wouter Korver files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →